Episode
1993: The Year Women Entered Clinical Trials & Why This Matters for Human Health (With Jessica Federer)
- Podcast
- Innovate and Elevate
- Published
- Apr 23, 2026
- Duration seconds
- 1630
- Processing state
not_requested- Canonical source
- https://www.innovateandelevatepodcast.com/
Actions
POST https://stenobird.com/v1/public/podcasts/innovate-and-elevate-6703724/episodes/1993-the-year-women-entered-clinical-trials-why-this-matters-for-human-health-with-jessica-federer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/innovate-and-elevate-6703724/1993-the-year-women-entered-clinical-trials-why-this-matters-for-human-health-with-jessica-federer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
What happened in 1993 still affects medicine today. That was the year women were required to be included in NIH-funded clinical trials, a shift that helped begin correcting decades of male-centered medical research. In this powerful conversation, Sharon Kedar CFA sits down with Jessica Federer, former Chief Digital Officer at Bayer and Managing Director of The Women’s Health Fund, to explore why this moment matters not only for women’s health, but for human health, innovation, and the future of medicine. They discuss how exclusion from research shaped diagnostics, drug dosing, autoimmune disease, heart health, cancer care, and why one of the world’s largest multi-trillion dollar industries still has enormous opportunity ahead. This Episode Is For You If: - You want to understand why women’s health impacts everyone - You’re curious how clinical trials shape modern medicine - You care about innovation, investing, longevity, and better healthcare outcomes What You’ll Learn: - Why women were historically excluded from many clinical trials - How 1993 changed medical research standards - Why better science creates better care for everyone Key Takeaways - Clinical research has historically relied heavily on male data, creating downstream gaps in care. - Including women in research improves diagnostics, treatment, safety, and outcomes across medicine. - Women’s health may be one of the greatest innovation opportunities of our time. Connect with Sharon: Connect with Sharon on LinkedIn: https://www.linkedin.com/in/sharonkedar/ Learn more about Innovate and Elevate: https:// innovateandelevatepodcast.com Subscribe to Innovate and Elevate on YouTube: https://www.youtube.com/channel/UCuWi1O9RBaPMYuCkKszPYVA Join the newsletter to receive the latest episodes in your inbox: https://i…